These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25281403)
21. Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells. Miao ZH; Tang T; Zhang YX; Zhang JS; Ding J Int J Cancer; 2003 Aug; 106(1):108-15. PubMed ID: 12794765 [TBL] [Abstract][Full Text] [Related]
22. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity. Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141 [TBL] [Abstract][Full Text] [Related]
23. Tooniliatone A sensitizes multidrug resistant cancer cells by decreasing Bcl-xL via activation of JNK MAPK signaling. Li Y; Xia YZ; Hu SM; Kong LY; Yang L Phytomedicine; 2019 Sep; 62():152947. PubMed ID: 31102887 [TBL] [Abstract][Full Text] [Related]
24. [Effect of desferrioxamine on K562/A02 cell line and its mechanism]. Cheng J; Wang T; Chen BA; Ding JH; Gao C; Xia GH; Bao W; Song HH; Xu WL; Shen HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):337-41. PubMed ID: 21518484 [TBL] [Abstract][Full Text] [Related]
25. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02]. Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598 [TBL] [Abstract][Full Text] [Related]
26. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling. Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis. Qi J; Liu N; Zhou Y; Tan Y; Cheng Y; Yang C; Zhu Z; Xiong D Biochem Biophys Res Commun; 2006 Oct; 349(1):303-9. PubMed ID: 16934756 [TBL] [Abstract][Full Text] [Related]
28. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells. Chen JR; Jia XH; Wang H; Yi YJ; Li YJ Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418 [TBL] [Abstract][Full Text] [Related]
29. [Effects of hyperbaric oxygen combined with adriamycin in inducing apoptosis of K562/A02 cells]. Zhang W; Chen BA; Bao W; Cheng J; Sun Y; Cheng J; Zhang M; Zhang XM; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):621-5. PubMed ID: 21729536 [TBL] [Abstract][Full Text] [Related]
30. [Role of WAVE1 in drug resistance of K562/A02 leukemia cells]. Kang R; Cao LZ; Yu Y; Hu T; Wang Z; Xu WQ; Xie M Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):379-82. PubMed ID: 17939402 [TBL] [Abstract][Full Text] [Related]
31. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells]. Sun YL; Zhou GY; Li KN; Li WT; Song XR; Gao P Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):518-21. PubMed ID: 15949329 [TBL] [Abstract][Full Text] [Related]
32. [Enhancive effect of HMGB1 gene silence on adriamycin-induced apoptosis in K562/A02 drug resistance leukemia cells]. Xie M; Kang R; Yu Y; Zhu S; He YL; Xu WQ; Tang DL; Cao LZ Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):549-52. PubMed ID: 19112920 [TBL] [Abstract][Full Text] [Related]
33. [Effect of CD44 gene silence on multi-drug resistance reversal and biologic activity in K562/A02 cells]. Liu YP; Liu CF; Ma DX; Lu F; Zhang JJ; Kong HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):335-9. PubMed ID: 20416163 [TBL] [Abstract][Full Text] [Related]
34. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1. Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441 [TBL] [Abstract][Full Text] [Related]
35. Expression profile of Notch-related genes in multidrug resistant K562/A02 cells compared with parental K562 cells. Yan S; Ma D; Ji M; Guo D; Dai J; Zhao P; Ji C Int J Lab Hematol; 2010 Apr; 32(2):150-8. PubMed ID: 19302234 [TBL] [Abstract][Full Text] [Related]
36. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway. Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993 [TBL] [Abstract][Full Text] [Related]
37. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528 [TBL] [Abstract][Full Text] [Related]
38. [Reversal of multi-drug resistance in K562/A02 cells by two short hairpin RNAs (shRNA) of mdr1]. Yu HQ; Ji CY; Ma DX; Zang SL Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):456-60. PubMed ID: 17147248 [TBL] [Abstract][Full Text] [Related]
39. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway. Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650 [TBL] [Abstract][Full Text] [Related]
40. [Effect of ribosomal protein L6 on drug resistance and apoptosis in K562/A02 cells]. Chen H; Xie ZX; Jiang H; Zhang ZW; Wang GP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):292-5. PubMed ID: 17493334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]